Indian contractor Syngene throws down $37M for Emergent's Baltimore biologics plant
10th March 2025 Uncategorised 0Indian CRDMO Syngene International is paying $36.5 million to acquire Emergent BioSolutions’ shuttered Bayview biologics facility in Baltimore. Syngene ultimately plans to invest around $50 million in the site, which is equipped with multiple production lines for monoclonal antibodies.
More: Indian contractor Syngene throws down M for Emergent's Baltimore biologics plant
Source: fierce